Type 1 diabetes and Dexcom
Because everyone’s diabetes needs, health goals and lifestyles are different, we offer a range of CGM systems that adapt to you.
Find out how Dexcom real-time CGM systems can help you better manage your Type 1 diabetes and give you greater control.
Type 2 diabetes and Dexcom
Dexcom real-time CGM systems are designed to fit around you and your lifestyle. With our discreet sensors, you can view insights and trends,empowering you to make impactful changes - all without finger pricks* or scanning. Discover how Dexcom CGM can give you the confidence to better manage your diabetes, and explore NHS funding options.
The Dexcom CGM Difference
Pioneer and leader in Real-Time CGM, Dexcom's goal is to simplify and improve diabetes management for every possible person with diabetes.
Real-time Glucose Readings.
No finger pricks*. No scanning.
Exceptional Accuracy†
Better informed treatment desicions.‡
Intuitive features.
Customisable alerts.
Proven Results.
Lower HbA1C. More time-in-range.1-5
*Finger pricks required for diabetes treatment decisions if symptoms or expectations do not match readings.
Find the right Dexcom CGM for you
Whatever your diabetes needs are, we have a Real-Time CGM for you. Explore our range of products.
rt-CGM made more accessible
Best for people with type 1 or type 2 diabetes using insulin looking for an easy and accessible real-time CGM system.
Best for people with type 1 or type 2 diabetes using insulin looking for an easy and accessible real-time CGM system.
Industry-leading connectivity
Best for people with type 1 diabetes who want connectivity with insulin delivery systems and health or lifestyle apps.
Best for people with type 1 diabetes who want connectivity with insulin delivery systems and health or lifestyle apps.
Powerfully simple
Best for people with type 1 diabetes who may need extra support, such as people who are hypo unaware, pregnant or children.
Best for people with type 1 diabetes who may need extra support, such as people who are hypo unaware, pregnant or children.
“Diabetes should not be a barrier to achieving your ambitions and dreams.”
“Dexcom CGM has been the biggest game-changer in my diabetes management to date. The anxiety I had experienced eased, my management improved. I was able to see my glucose by simply seeing down to my wrist§ and able to make treatment decisions there and then. I feel so much more confident on stage and in the practice room teaching.”
Lucy F., Dexcom Warrior
T1D, 22 Years
T1D, 22 Years
The featured Warrior is a sponsored spokesperson of Dexcom.
Additional Support
Whether you’re a new Dexcom customer or just have a question, we’re here to help.
NHS Funding for Dexcom
Dexcom CGM can be offered to people with type 1 diabetes by the NHS.
New to Dexcom?
Get started on your journey to zero finger pricks* or scanning with our simple self-guided training programme.
Take the Next Step
Joining the Dexcom family is easy. Simply click the link below to get started.
References:
* Finger pricks required for diabetes treatment decisions if symptoms or expectations do not match readings.
† Dexcom G6 and Dexcom G7 User Guides.
‡ Discuss with your HCP on how to use CGM information to manage diabetes.
§ For a list of compatible smart devices, please visit www.dexcom.com/compatibility.
1 Beck RW, et al. JAMA. 2017;317(4):371-378.
2 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.
3 Aleppo G, et al. Diabetes Care. 2021;44(12):2729-2737.
4 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
5 Lind M, et al. Diabetes Care. 2021;44(1):141-149.
* Finger pricks required for diabetes treatment decisions if symptoms or expectations do not match readings.
† Dexcom G6 and Dexcom G7 User Guides.
‡ Discuss with your HCP on how to use CGM information to manage diabetes.
§ For a list of compatible smart devices, please visit www.dexcom.com/compatibility.
1 Beck RW, et al. JAMA. 2017;317(4):371-378.
2 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.
3 Aleppo G, et al. Diabetes Care. 2021;44(12):2729-2737.
4 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
5 Lind M, et al. Diabetes Care. 2021;44(1):141-149.
LBL–1004542 Rev001